Publications

Export 43 results:
Author [ Title(Desc)] Type Year
Filters: Author is Judes Poirier  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Picard C, Julien C, Frappier J, Miron J, Théroux L, Dea D, Breitner JCS, Poirier J.  2018.  Alterations in cholesterol metabolism-related genes in sporadic Alzheimer's disease.. Neurobiol Aging. 66:180.e1-180.e9.
Bombardier A, Beauchemin M, Gosselin N, Poirier J, De Beaumont L.  2016.  Altered Episodic Memory in Introverted Young Adults Carrying the BDNFMet Allele.. Int J Mol Sci. 17(11)
Poirier J, Gauthier S.  2014.  Alzheimer’s disease. The Complete Introduction.
Konishi K, Bhat V, Banner H, Poirier J, Joober R, Bohbot VD.  2016.  APOE2 Is Associated with Spatial Navigational Strategies and Increased Gray Matter in the Hippocampus.. Front Hum Neurosci. 10:349.
Poirier J, Miron J, Picard C, Gormley P, Théroux L, Breitner JCS, Dea D.  2014.  Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease.. Neurobiol Aging. 35 Suppl 2:S3-10.
Fiocco AJ, D'Amico D, De Beaumont L, Poirier J, Lupien S.  2019.  Association between BDNF Polymorphism and Hypothalamic-Pituitary-Adrenal Activity in Later Adulthood.. Gerontology. :1-7.
Miron J, Picard C, Labonte A, Auld D, Breitner JCS, Poirier J.  2019.  Association of PPP2R1A with Alzheimer's disease and specific cognitive domains.. Neurobiol Aging. 81:234-243.
Miron J, Picard C, Lafaille-Magnan M-E, Savard M, Labonte A, Breitner JCS, Rosa-Neto P, Auld D, Poirier J.  2019.  Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammation.. Alzheimers Dement. 15(7):951-960.
Liebsch F, Kulic L, Teunissen C, Shobo A, Ulku I, Engelschalt V, Hancock MA, van der Flier WM, Kunach P, Rosa-Neto P et al..  2019.  Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression.. Nat Commun. 10(1):2240.
B
Taschereau-Dumouchel V, Hétu S, Michon P-E, Vachon-Presseau E, Massicotte E, De Beaumont L, Fecteau S, Poirier J, Mercier C, Chagnon YC et al..  2016.  BDNF Val(66)Met Polymorphism Influences Visuomotor Associative Learning and the Sensitivity to Action Observation.. Sci Rep. 6:34907.
Gosselin N, De Beaumont L, Gagnon K, Baril A-A, Mongrain V, Blais H, Montplaisir J, Gagnon J-F, Pelleieux S, Poirier J et al..  2016.  BDNF Val66Met Polymorphism Interacts with Sleep Consolidation to Predict Ability to Create New Declarative Memories.. J Neurosci. 36(32):8390-8.
Meyer P-F, Savard M, Poirier J, Labonte A, Rosa-Neto P, Weitz TM, Town T, Breitner JCS.  2018.  Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer's Disease Pathogenesis.. J Alzheimers Dis. 63(2):577-590.
Vogel JW, Vachon-Presseau E, Binette APichet, Tam A, Orban P, La Joie R, Savard M, Picard C, Poirier J, Bellec P et al..  2018.  Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease.. Brain. 141(6):1871-1883.
De Beaumont L, Pelleieux S, Lamarre-Théroux L, Dea D, Poirier J.  2016.  Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.. J Alzheimers Dis. 54(3):913-922.
C
Miron J, Picard C, Nilsson N, Frappier J, Dea D, Théroux L, Poirier J.  2018.  CDK5RAP2 gene and tau pathophysiology in late-onset sporadic Alzheimer's disease.. Alzheimers Dement.
Lelental N, Brandner S, Kofanova O, Blennow K, Zetterberg H, Andreasson U, Engelborghs S, Mroczko B, Gabryelewicz T, Teunissen C et al..  2016.  Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics.. J Alzheimers Dis. 52(1):51-64.
Chertkow H, Borrie M, Whitehead V, Black SE, Feldman HH, Gauthier S, Hogan DB, Masellis M, McGilton K, Rockwood K et al..  2019.  The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort Study.. Can J Neurol Sci. 46(5):499-511.
D
Tuwaig M, Savard M, Jutras B, Poirier J, D Collins L, Rosa-Neto P, Fontaine D, Breitner JCS.  2017.  Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer's Disease.. J Alzheimers Dis. 60(4):1589-1600.
Gan-Or, iv Z, Montplaisir JY, Ross JP, Poirier J, Warby SC, Arnulf I, Strong S, Dauvilliers Y, Leblond CS, Hu MTM et al..  2017.  The dementia-associated APOE ε4 allele is not associated with rapid eye movement sleep behavior disorder.. Neurobiol Aging. 49:218.e13-218.e15.
Jasmin SBélanger, Pearson V, Lalonde D, Domenger D, Théroux L, Poirier J.  2014.  Differential regulation of ABCA1 and ABCG1 gene expressions in the remodeling mouse hippocampus after entorhinal cortex lesion and liver-X receptor agonist treatment.. Brain Res. 1562:39-51.
E
Leduc V, Théroux L, Dea D, Dufour R, Poirier J.  2016.  Effects of rs3846662 Variants on HMGCR mRNA and Protein Levels and on Markers of Alzheimer's Disease Pathology.. J Mol Neurosci. 58(1):109-19.
Benedet AL, Labbe A, Lemay P, Zimmer ER, Pascoal TA, Leuzy A, Mathotaarachchi S, Mohades S, Shin M, Dionne-Laporte A et al..  2015.  Epistasis analysis links immune cascades and cerebral amyloidosis.. J Neuroinflammation. 12:227.
F
Schoemaker D, Poirier J, D Collins L, Gauthier S, Pruessner JC.  2017.  Familiarity deficits in cognitively normal aging individuals with APOE ε4: A follow-up investigation of medial temporal lobe structural correlates.. Alzheimers Dement (Amst). 9:21-24.
H
Konishi K, Joober R, Poirier J, MacDonald K, M Chakravarty M, Patel R, Breitner JCS, Bohbot VD.  2018.  Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease.. J Alzheimers Dis. 61(4):1493-1507.
Leduc V, De Beaumont L, Théroux L, Dea D, Aisen P, Petersen RC, Dufour R, Poirier J.  2015.  HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study.. Mol Psychiatry. 20(7):867-73.

Pages